Treatment of heroin dependence with buprenorphine in primary care.
about
Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A ReviewA multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodologyBuprenorphine treatment in an urban community health center: what to expectHome- versus office-based buprenorphine inductions for opioid-dependent patients.Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.Conducting clinical research with prescription opioid dependence: defining the population.Factors affecting willingness to provide buprenorphine treatment.Opioid dependence treatment: options in pharmacotherapy.Patients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care.Integrating buprenorphine treatment into office-based practice: a qualitative studyBuprenorphine: new treatment of opioid addiction in primary care.A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphineThe association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.Prevention of HIV infection among injection drug users in resource-limited settings.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatmentTreating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.Provider satisfaction with office-based treatment of opioid dependence: a systematic review.Evidenced-based treatment of opioid-dependent patients.A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.Adoption of medications in substance abuse treatment: priorities and strategies of single state authoritiesA pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomesCounselor training and attitudes toward pharmacotherapies for opioid use disorder.Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies.Comorbid pain and opioid addiction: psychosocial and pharmacological treatments.Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's office-based Buprenorphine Pilot Program.Primary care models for treating opioid use disorders: What actually works? A systematic reviewComparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening.Coordination of medical care and opioid dependence treatment in primary care: a case report.Research to practice: adoption of naltrexone in alcoholism treatment.Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 2: populations particulières.Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities.Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists
P2860
Q26785483-7CB1F0B5-43F4-4031-86F1-0C0EEF6E5CBBQ33699066-638BE67E-AB80-46F9-8C5A-D011C48486F1Q33735289-33377385-EA6A-48C1-A5AB-3813B9739F0AQ33769847-CD4670A8-B039-43E4-9ACC-4FEB43F6D70DQ33776944-AF9E593C-798B-4BD5-84E6-52B74F1EBE2DQ33779302-015083DE-DF6F-4292-9F44-A045829575CDQ33836333-7270F27E-7F45-4D49-9031-D7635C694B41Q33868638-3AD337DC-06A4-4FD1-8BD8-B3075CCEF67BQ34408522-3CA10A38-080C-4378-B13F-D7DD682D3DD4Q34602077-4C0D4EDF-51F4-45F2-8238-CD426294AEE0Q34667890-F1B63705-ECEC-46D4-817E-6F158A55EB40Q34980314-7AE93D25-0BAD-4F1A-999A-DE2FBAC12325Q35023292-66CBBC3E-6214-4217-899D-1A5FC0CC34F3Q35043964-297F24BD-4D86-461C-BDEF-2A66A10E1F13Q35548503-5AC09709-9D09-48D8-9D73-1FC69F2711F2Q35683154-E7A9E609-966F-491D-AAFD-D81A22B821E0Q35686969-B4F9D5E0-C08B-49CC-9200-57D1C47289EBQ35687716-4E46EDD6-5084-4055-8430-890C07B0E98AQ35691511-30D08FAB-B0F2-4B06-ACC5-9EA23B303E32Q36364490-445F9B11-58B2-4A79-9E0C-73F8FC99376BQ36367544-F0449C36-CFAB-461C-9849-147FEC4340ECQ36402982-F6E29C1B-036D-4BBC-9D6F-469459EB98E6Q36628470-A7EE106B-82C4-48AE-89AC-E36760BD6D60Q36753425-D35D2B16-DD93-4568-96E0-3701A51F981EQ36806539-A7D1D22E-F1F0-4684-9BB2-8E3C4DEF90FDQ36926561-0921CD9B-A60A-45C7-ADA2-D6B3192310D2Q36934945-6F2E7045-26A3-4680-A41B-F9B77B34773CQ36984354-703D1433-68D8-4754-BE11-5FEC8C146974Q37355278-442BB4D6-CC03-432C-ADA5-C0589A3C1357Q37901021-E4F1A859-B13A-4F88-B1FD-228FF7B79271Q39029605-2DB73772-C664-4F8C-8F16-C55AFDE764F6Q39995581-B3EF9FD8-56A5-4A7E-934E-B34004DBFC95Q42656779-DE903EBD-5924-4C47-914F-3FC23808CBDFQ43218767-E9FB50CB-7F83-461E-82FA-0AFFAAF6674AQ44340899-CE02C5C6-11EB-43DA-9473-B6F355DEA51CQ44368411-B0AFDFD2-745F-4685-9819-048CC004D562Q45871173-B5C88583-B62B-4DE1-89D3-55FBF4309B6CQ46416517-3652D48A-56D3-4FFA-8C10-B14499DFEC37Q47561425-6E92D27E-E474-414B-A14E-C97272BB72D8Q57128664-E64078B0-EDC7-46AF-8A41-3A855398EB02
P2860
Treatment of heroin dependence with buprenorphine in primary care.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Treatment of heroin dependence with buprenorphine in primary care.
@en
Treatment of heroin dependence with buprenorphine in primary care.
@nl
type
label
Treatment of heroin dependence with buprenorphine in primary care.
@en
Treatment of heroin dependence with buprenorphine in primary care.
@nl
prefLabel
Treatment of heroin dependence with buprenorphine in primary care.
@en
Treatment of heroin dependence with buprenorphine in primary care.
@nl
P2093
P2860
P356
P1476
Treatment of heroin dependence with buprenorphine in primary care.
@en
P2093
Juliana P Pakes
Marek Chawarski
Michael V Pantalon
Patrick G O'Connor
Richard S Schottenfeld
P2860
P304
P356
10.1081/ADA-120002972
P577
2002-01-01T00:00:00Z